626
Participants
Start Date
March 31, 2011
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Roflumilast
Roflumilast tablets
Placebo
Placebo tablets
Salbutamol
Salbutamol (given by MDI and spacer) used as rescue medication on an ass needed basis throughout the trial, and was used for post-bronchodilator spirometry tests at all study visits.
Beijing
Changsha
Chengdu
Chongqing
Fuzhou
Guangzhou
Hangzhou
Nanjing
Nanning
Qingdao
Shanghai
Shenyang
Shijiazhuang
Hong Kong
Singapore
Lead Sponsor
AstraZeneca
INDUSTRY